The attendee will be able to:

1. Compare and contrast how the QP role may or may not be impacted based on the various BREXIT scenarios.
2. Identify when the UK will have to exit the EU.
3. Explain no less than two mitigations for QP release in a UK based Clinical Supply Chain.